IgA1 from the SLE patients also presented less VVL staining (Tn antigen) and more terminal GlcNAc (GSL-II lectin) motives than that from the HDs, indicating a decrease in terminal galactosylation. The gene discussed is IGHA1; the disease is systemic lupus erythematosus.